Format

Send to

Choose Destination
J Pediatr Hematol Oncol. 2011 Jan;33(1):e39-42. doi: 10.1097/MPH.0b013e3181e75747.

A unique clinical presentation of X-linked lymphoproliferative syndrome with a novel mutation in SH2D1A and review of the literature.

Author information

1
Department of Pediatrics, Division of Hematology/Oncology, Vanderbilt University, School of Medicine, USA.

Abstract

X-linked lymphoproliferative syndrome is a well-described syndrome often characterized by progression to fatal infectious mononucleosis. Many mutations of the SH2D1A gene have been identified in patients with X-linked lymphoproliferative syndrome. These mutations are often associated with either decreased or impaired function of the protein product, signaling lymphocytic activation molecule-associated protein. We describe a patient with a novel missense mutation in SH2D1A. We report on his unique presentation, clinical course and subsequent successful treatment with a matched unrelated donor bone marrow transplant.

PMID:
20975587
DOI:
10.1097/MPH.0b013e3181e75747
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center